<?xml version="1.0" encoding="UTF-8"?>

<!--L
  Copyright Oracle Inc

  Distributed under the OSI-approved BSD 3-Clause License.
  See http://ncip.github.com/cadsr-cgmdr-nci-uk/LICENSE.txt for details.
L-->

<cgMDR:Enumerated_Conceptual_Domain xmlns:cgMDR="http://www.cancergrid.org/schema/cgMDR" item_registration_authority_identifier="US-NCICB-CACORE" data_identifier="D1E155151" version="1">
    <cgMDR:administered_item_administration_record>
        <cgMDR:administrative_status>noPendingChanges</cgMDR:administrative_status>
        <cgMDR:creation_date>2007-07-17</cgMDR:creation_date>
        <cgMDR:effective_date>2007-07-17</cgMDR:effective_date>
        <cgMDR:explanatory_comment>Transformed from NCICB caDSR</cgMDR:explanatory_comment>
        <cgMDR:last_change_date>2007-07-17</cgMDR:last_change_date>
        <cgMDR:registration_status>Standard</cgMDR:registration_status>
    </cgMDR:administered_item_administration_record>
    <cgMDR:administered_by>US-NCICB-CTEP-STEWARD</cgMDR:administered_by>
    <cgMDR:registered_by>US-NCICB-CACORE-REGISTRAR</cgMDR:registered_by>
    <cgMDR:submitted_by>US-NCICB-CTEP-SUMBMITTER</cgMDR:submitted_by>
    <cgMDR:having>
        <cgMDR:context_identifier>US-NCICB-CTEP-1</cgMDR:context_identifier>
        <cgMDR:containing>
            <cgMDR:language_section_language_identifier>
                <cgMDR:country_identifier>US</cgMDR:country_identifier>
                <cgMDR:language_identifier>eng</cgMDR:language_identifier>
            </cgMDR:language_section_language_identifier>
            <cgMDR:name>Adverse Events</cgMDR:name>
            <cgMDR:definition_text/>
            <cgMDR:preferred_designation>true</cgMDR:preferred_designation>
            <cgMDR:definition_source_reference/>
        </cgMDR:containing>
        <cgMDR:containing>
            <cgMDR:language_section_language_identifier>
                <cgMDR:country_identifier>US</cgMDR:country_identifier>
                <cgMDR:language_identifier>eng</cgMDR:language_identifier>
            </cgMDR:language_section_language_identifier>
            <cgMDR:name>AE</cgMDR:name>
            <cgMDR:definition_text/>
            <cgMDR:preferred_designation>false</cgMDR:preferred_designation>
            <cgMDR:definition_source_reference/>
        </cgMDR:containing>
    </cgMDR:having>
    <cgMDR:dimensionality/>
    <cgMDR:Value_Meaning>
        <cgMDR:value_meaning_begin_date >2007-07-17</cgMDR:value_meaning_begin_date>
        <cgMDR:value_meaning_description >NONE</cgMDR:value_meaning_description>
        <cgMDR:value_meaning_identifier >D1E155153</cgMDR:value_meaning_identifier>
    </cgMDR:Value_Meaning>
    <cgMDR:Value_Meaning>
        <cgMDR:value_meaning_begin_date >2007-07-17</cgMDR:value_meaning_begin_date>
        <cgMDR:value_meaning_description >DEATH</cgMDR:value_meaning_description>
        <cgMDR:value_meaning_identifier >D1E155162</cgMDR:value_meaning_identifier>
    </cgMDR:Value_Meaning>
    <cgMDR:Value_Meaning>
        <cgMDR:value_meaning_begin_date >2007-07-17</cgMDR:value_meaning_begin_date>
        <cgMDR:value_meaning_description >Life-threatening consequences</cgMDR:value_meaning_description>
        <cgMDR:value_meaning_identifier >D1E155171</cgMDR:value_meaning_identifier>
    </cgMDR:Value_Meaning>
    <cgMDR:Value_Meaning>
        <cgMDR:value_meaning_begin_date >2007-07-17</cgMDR:value_meaning_begin_date>
        <cgMDR:value_meaning_description >Requiring transfusion of 2 units non-autologous (10 cc/kg for
                  pediatrics) pRBCs beyond protocol specification; postoperative interventional
                  radiology, endoscopic, or operative intervention indicated</cgMDR:value_meaning_description>
        <cgMDR:value_meaning_identifier >D1E155180</cgMDR:value_meaning_identifier>
    </cgMDR:Value_Meaning>
</cgMDR:Enumerated_Conceptual_Domain>